International Sales Grow 17% Year-Over-Year; Including 45% Refractive
Cash Used For Operations Reduced By 54% Compared With Q207
Gross Margin Expands 2.1% Year-Over-Year to 49.7%
MONROVIA, Calif., Oct. 30 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced financial results for its third quarter ended September 28, 2007.
Total product sales for the third quarter were $13,629,000, an increase of 2.4% compared with $13,313,000 reported for the same period of 2006. The year-over-year increase in sales during the third quarter of 2007 was the result of increased international sales, which grew 17% compared with the third quarter of 2006. Global cataract sales in the third quarter of 2007 declined by 1.5% compared with the same quarter of 2006, while total refractive sales grew 17.1%. The favorable impact of changes in currency on third quarter 2007 sales was approximately $471,000.
For the first nine months of 2007, total product sales were $43,478,000, an increase of 4.7% compared with the same period of last year. The increase in sales during the first nine months of 2007 was also led by strong international product sales, which grew 16.6% during this period. The favorable impact of changes in currency on sales in the first nine months of 2007 was approximately $1,462,000.
International sales for the third quarter of 2007 were $8,890,000, up
16.9% compared with $7,608,000 reported in the same period of last year.
Third quarter international refractive sales were $2,290,000, up 44.9%
compared with the third quar
|SOURCE STAAR Surgical Company|
Copyright©2007 PR Newswire.
All rights reserved